Ultragenyx Pharmaceutical
RARE
#4530
Rank
HK$17.29 B
Marketcap
HK$175.91
Share price
4.81%
Change (1 day)
-35.57%
Change (1 year)

P/S ratio for Ultragenyx Pharmaceutical (RARE)

P/S ratio as of April 2026 (TTM): 3.28

According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -30.2. At the end of 2025 the company had a P/S ratio of 3.38.

P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.38-52.73%
20247.16-20.85%
20239.041.15%
20228.94-45.19%
202116.3-51.73%
202033.841.86%
201923.8-44.54%
201842.9-94.32%
2017756-96.5%
2016> 1000
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Lexicon Pharmaceuticals
LXRX
9.51 189.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
2.21-32.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.15 117.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.31 1.03%๐Ÿ‡บ๐Ÿ‡ธ USA